Celestial Biolabs to launch 100%
veg antibiotic for diabetes
New Delhi: Bio-pharmaceutical
company Celestial Biolabs is set to launch an antibiotic product for the
treatment of diabetes. ‘The company is in the process of this natural sea based
100 percent vegetarian product tenatatively by April 2015,’ Celestial Biolabs
said in a filing to the BSE.
Earlier in 2013, the Hyderabad-based company launched its
patented arthiritis management product, Cadalmin GAe. Celestial Biolabs is
currently engaged in the business of manufacturing and sale of
bio-pharmaceutical products. Shares of the company today closed at Rs
47.40 on the BSE, up 5.22 per cent from previous close.
Source: www.thehealthsite.com
14.01.2015
Fish compound can fight against
heart disease
A peptide originally found in fish could be used in
the battle against cardiovascular disease, research has found. The peptide
Urotensin II (UII) was first isolated from teleost fish, a class of ray-finned
fishes. UII can modulate a vast array of biologic activities encompassing the
cardiovascular system, kidneys and central nervous system, the findings showed.
‘We have been working on this exciting peptide for a
number of years; it exhibits a very interesting pharmacological profile. Design
and evaluation of small molecule drugs has potential for use in the treatment
of several cardiovascular diseases,’ said professor David Lambert from the
University of Leicester in Britain. Interestingly, the peptide can constrict
some blood vessels yet dilate others, the researchers noted. The study appeared
in the journal Pharmacological Reviews.
Source: www.thehealthsite.com
14.01.2015
Believe and act as if it were impossible to
fail
Charles Kettering
No comments:
Post a Comment